Physician profile
Joseph Simmert
NPI 1124120894
$2,698.15
in general payments reported to CMS, 2019-2025
15 companies · $535 in 2025
The $535 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $84.28 · 2021: $321 · 2022: $523 · 2023: $458 · 2024: $673 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,665.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $547.14 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $534.39 | 2020-2024 | Jornay Pm |
| Corium, LLC | $493.70 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $194.99 | 2025 | Jornay Pm |
| Pfizer INC. | $188.56 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $186.44 | 2020-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Glaxosmithkline, LLC. | $167.40 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Vertical Pharmaceuticals, LLC | $92.01 | 2019-2024 | Relexxii |
| Tris Pharma INC | $65.75 | 2020-2024 | Onyda Xr |
| Sanofi Pasteur INC. | $62.13 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $54.95 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $53.08 | 2025 | Daybue |
| Biomarin Pharmaceutical INC. | $24.11 | 2023 | Voxzogo 1.2mg |
| Hologic Sales and Service, LLC | $20.28 | 2024 | Aptima |
| Cranial Technologies, INC | $13.22 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Simmert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.